85325-12-8Relevant academic research and scientific papers
USE OF 2-AMINO-2H-QUINAZOLINE DERIVATIVES FOR PRODUCING THERAPEUTIC AGENTS
-
Page/Page column 10, (2010/02/07)
The invention relates to the use of 2-amino-2H-quinazoline derivatives of general chemical formula (I), wherein R1 represents an alkyl group having 1 - 5 carbon atoms and R2, R3, R4 and R5 independently represent a chlorine or hydrogen atom, in addition to the pharmaceutically compatible salts thereof for producing therapeutic agents for treating myeloproliferative diseases, high blood pressure and bronchodilation.
Process for the preparation of ethyl-N-(2,3 dichloro-6-nitrobenzyl) glycine
-
, (2008/06/13)
The known blood platelet reducing agent Anagrelide is prepared via an improved process starting with commercially available 2,3-dichlorotoluene and involving novel intermediates represented by the formulas: STR1 wherein Y is Br, Cl or I. Compound (G) is r
